Multilevel Monte Carlo Estimation of the Expected Value of Sample Information
read more
Citations
Computing the Expected Value of Sample Information Efficiently: Practical Guidance and Recommendations for Four Model-Based Methods.
Unbiased MLMC stochastic gradient-based optimization of Bayesian experimental designs.
Nonlinear Monte Carlo methods with polynomial runtime for high-dimensional iterated nested expectations.
Value of Information Analysis in Models to Inform Health Policy
Unbiased MLMC Stochastic Gradient-Based Optimization of Bayesian Experimental Designs
References
Monte Carlo Statistical Methods
Monte Carlo strategies in scientific computing
Inverse problems: A Bayesian perspective
Multilevel Monte Carlo Path Simulation
Multilevel Monte Carlo methods and applications to elliptic PDEs with random coefficients
Related Papers (5)
Efficient Monte Carlo Estimation of the Expected Value of Sample Information Using Moment Matching
An adaptive Monte Carlo algorithm for computing mixed logit estimators
Frequently Asked Questions (9)
Q2. How many times is the standard error equal to 0.66?
Repeating the standard Monte Carlo estimation with 108 i.i.d. samples of \\theta 10 times, EVPI is estimated as 4,063.5 with the standard error equal to 0.66.
Q3. What is the way to estimate the bias?
It should be noted that the values of both \\alpha and \\beta are estimated on the fly as the computation is performed, with the value of \\alpha being used to determine when the bias \\BbbE [P - PL] has converged sufficiently as L increases.
Q4. How many inner samples are needed to ensure that din din d?
For the outer samples of Y which are far away from the decision manifold K, a smaller number of inner samples than M02 \\ell may be sufficient to ensure thatargmax d\\in D gd = argmax d\\in Dgd (a) = argmaxd\\in D gd(b) = d\\mathrm{o}\\mathrm{p}\\mathrm{t}holds with high probability.
Q5. how many treatments do you use to determine the probability of a critical event?
Probability of critical event PE,d Derived from on treatments d = 2, 3 PE,1 and ORE,d Probability of side effect PSE,1 0 (constant) on treatment d = 1Probability of side effect PSE,d logit-normal \\biggl( \\biggl( - 1.4 - 1.1 \\biggr) , \\biggl( 0.10 0.05 0.05 0.25 \\biggr) \\biggr) on treatments d = 2, 3 Monetary value of 1 QALY \\lambda $75,000 (constant)2.
Q6. How much does a multicenter RCT cost?
This hypothetical multicenter RCT costs $200,000 for setup, $1500 for each randomized patient, and $50,000 for each additional 100 patients added to the study (owing to the cost of establishing a new center).
Q7. what is the pmax of bigm| bigm| ?
For the second term, when \\bigm| \\bigm| \\rho (Y | \\cdot )/\\rho (Y ) - 1\\bigm| \\bigm| \\leq 1/2 the authors have| gd - Gd| p \\leq 2p - 1 \\bigm| \\bigm| \\bigm| \\bigm| \\bigm| fd(\\cdot )\\rho (Y | \\cdot )\\rho (Y | \\cdot ) - Fd(Y )\\rho (Y | \\cdot ) \\bigm| \\bigm| \\bigm| \\bigm| \\bigm| p + 2p - 1 \\bigm| \\bigm| \\bigm| \\bigm| \\bigm| Fd(Y )\\rho (Y | \\cdot ) - Fd(Y )\\rho (Y ) \\bigm| \\bigm| \\bigm| \\bigm| \\bigm| p\\leq 2 2p - 1\\rho (Y )p \\bigm| \\bigm| \\bigm| fd(\\cdot )\\rho (Y | \\cdot ) - Fd(Y )\\bigm| \\bigm| \\bigm| p + 22p - 1F pmax \\bigm| \\bigm| \\bigm| \\bigm| \\bigm| \\rho (Y | \\cdot )\\rho (Y ) - 1 \\bigm| \\bigm| \\bigm| \\bigm| \\bigm| p ,and therefore, again by Lemma 3.8,\\BbbE [| gd - Gd| p1Ec ] \\leq 22p - 1 - p\\ell /2M - p/2 0 Cp\\BbbE Y \\biggl[ \\BbbE \\theta \\biggl[ \\bigm| \\bigm| \\bigm| \\bigm| fd(\\theta )\\rho (Y | \\theta ) - Fd(Y )\\rho (Y ) \\bigm| \\bigm| \\bigm| \\bigm| p\\biggr] \\biggr] + 22p - 1 - p\\ell /2M - p/2 0 CpF p max\\BbbE Y \\biggl[ \\BbbE \\theta \\biggl[ \\bigm| \\bigm| \\bigm| \\bigm| \\rho (Y | \\theta )\\rho (Y ) - 1 \\bigm| \\bigm| \\bigm| \\bigm| p\\biggr] \\biggr] .(3.2) Note that \\bigm| \\bigm| \\bigm| \\bigm| \\rho (Y | \\theta )\\rho (Y ) - 1 \\bigm| \\bigm| \\bigm| \\bigm| p \\leq max\\biggl( \\rho (Y | \\theta )\\rho (Y ) , 1 \\biggr) p \\leq \\biggl( \\rho (Y | \\theta ) \\rho (Y ) \\biggr) p + 1,which gives\\BbbE Y \\biggl[ \\BbbE \\theta \\biggl[ \\bigm| \\bigm| \\bigm| \\bigm| \\rho (Y | \\theta )\\rho (Y ) - 1 \\bigm| \\bigm| \\bigm| \\bigm| p\\biggr] \\biggr] \\leq \\BbbE Y \\biggl[ \\BbbE \\theta \\biggl[ \\biggl( \\rho (Y | \\theta )\\rho (Y ) \\biggr) p\\biggr] \\biggr] + 1.(3.3)Similarly,| fd(\\theta )\\rho (Y | \\theta ) - Fd(Y )| p \\leq 2p - 1 (| fd(\\theta )\\rho (Y | \\theta )| p + | Fd(Y )| p) \\leq 2p - 1F pmax(\\rho (Y | \\theta )p + \\rho (Y )p),which gives \\BbbE Y \\biggl[ \\BbbE \\theta \\biggl[ \\bigm| \\bigm| \\bigm| \\bigm| fd(\\theta )\\rho (Y | \\theta ) - Fd(Y )\\rho (Y ) \\bigm| \\bigm| \\bigm| \\bigm| p\\biggr] \\biggr] \\leq 2p - 1F pmax\\biggl( \\BbbE Y \\biggl[ \\BbbE \\theta \\biggl[ \\biggl( \\rho (Y | \\theta )\\rho (Y ) \\biggr) p\\biggr] \\biggr] + 1 \\biggr) .(3.4)Combining the bounds in (3.1) and (3.2), and then using (3.3) and (3.4), the authors get\\BbbE [ | gd - Gd| p] \\leq (3 \\cdot 22p - 1+23p - 2)2 - p\\ell /2M - p/2 0 CpF p max \\biggl( \\BbbE Y \\biggl[ \\BbbE \\theta \\biggl[ \\biggl( \\rho (Y | \\theta ) \\rho (Y ) \\biggr) p\\biggr] \\biggr] + 1 \\biggr) ,which completes the proof of the first assertion.
Q8. What is the MLMC estimator of EVPI?
This directly implies from Theorem 2.1 that their MLMC estimator of EVPI - EVSI achieves a root-mean-square accuracy \\varepsilon at a cost of optimal O(\\varepsilon - 2).
Q9. How many people will benefit from sampling?
Their final modification to improve practical relevance is to assume an annual population that experiences this disease as 2,500, a technology horizon of 10 years, and an annual discount factor of 1.035, giving a total discounted population that will benefit from sampling as 21,519.